Article Information
vol. 50 no. 2
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 2, 2016
- Accepted April 21, 2017
- Published online August 3, 2017.
Copyright & Usage
Copyright ©ERS 2017 This ERJ Open article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Mareike Lehmann1,
- Martina Korfei2,
- Kathrin Mutze1,
- Stephan Klee1,
- Wioletta Skronska-Wasek1,
- Hani N. Alsafadi1,
- Chiharu Ota1,
- Rita Costa1,
- Herbert B. Schiller1,
- Michael Lindner3,
- Darcy E. Wagner1,
- Andreas Günther2,4,5 and
- Melanie Königshoff1,6⇑
- 1Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München and University Hospital of the Ludwig Maximilians Universität, Member of the German Center for Lung Research (DZL), Munich, Germany
- 2Dept of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-Universität Giessen, Member of the German Center for Lung Research (DZL), Giessen, Germany
- 3Center for Thoracic Surgery, Asklepios Biobank for Lung Diseases, Comprehensive Pneumology Center, Asklepios Clinic Munich-Gauting, Munich, Germany
- 4Agaplesion Lung Clinic Waldhof Elgershausen, Greifenstein, Germany
- 5European IPF Network and European IPF Registry
- 6Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado, Denver, CO, USA
- Division of Pulmonary Sciences and Critical Care Medicine, Dept of Medicine, University of Colorado Denver, AMC, Research 2, 9th Flr, 12700 East 19th Ave, Aurora, CO 80045, USA. E-mail: melanie.koenigshoff{at}ucdenver.edu
Funding
Whitaker International Scholar Fellowship
Helmholtz Munich Postdoctoral Program
Helmholtz Association
German Center of Lung Research
Article usage
Altmetrics
Vol 50 Issue 2
Table of Contents
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
